abstract This is the fi rst clinical practice guideline from the American Academy of Pediatrics that specifi cally applies to patients who have experienced an apparent life-threatening event (ALTE). This clinical practice guideline has 3 objectives. First, it recommends the replacement of the term ALTE with a new term, brief resolved unexplained event (BRUE). Second, it provides an approach to patient evaluation that is based on the risk that the infant will have a repeat event or has a serious underlying disorder. Finally, it provides management recommendations, or key action statements, for lower-risk infants. The term BRUE is defi ned as an event occurring in an infant younger than 1 year when the observer reports a sudden, brief, and now resolved episode of ≥1 of the following: (1) cyanosis or pallor; (2) absent, decreased, or irregular breathing; (3) marked change in tone (hyper-or hypotonia); and (4) altered level of responsiveness. A BRUE is diagnosed only when there is no explanation for a qualifying event after conducting an appropriate history and physical examination. By using this defi nition and framework, infants younger than 1 year who present with a BRUE are categorized either as (1) a lower-risk patient on the basis of history and physical examination for whom evidence-based recommendations for evaluation and management are offered or (2) a higher-risk patient whose history and physical examination suggest the need for further investigation and treatment but for whom recommendations are not offered. This clinical practice guideline is intended to foster a patient-and family-centered approach to care, reduce unnecessary and costly medical interventions, improve patient outcomes, support implementation, and provide direction for future research. Each key action statement indicates a level of evidence, the benefi t-harm relationship, and the strength of recommendation.
INTRODUCTION
This clinical practice guideline applies to infants younger than 1 year and is intended for pediatric clinicians. This guideline has 3 primary objectives. First, it recommends the replacement of the term apparent life-threatening event (ALTE) with a new term, brief resolved unexplained event (BRUE). Second, it provides an approach to patient evaluation that is based on the risk that the infant will have a recurring event or has a serious underlying disorder. Third, it provides evidence-based management recommendations, or key action statements, for lower-risk patients whose history and physical examination are normal. It does not offer recommendations for higherrisk patients whose history and physical examination suggest the need for further investigation and treatment (because of insufficient evidence or the availability of clinical practice guidelines specific to their presentation). This clinical practice guideline also provides implementation support and suggests directions for future research.
The term ALTE originated from a 1986 National Institutes of Health Consensus Conference on Infantile Apnea and was intended to replace the term "near-miss sudden infant death syndrome" (SIDS). 1 An ALTE was defined as "an episode that is frightening to the observer and that is characterized by some combination of apnea (central or occasionally obstructive), color change (usually cyanotic or pallid but occasionally erythematous or plethoric), marked change in muscle tone (usually marked limpness), choking, or gagging. In some cases, the observer fears that the infant has died." 2 Although the definition of ALTE eventually enabled researchers to establish that these events are separate entities from SIDS, the clinical application of this classification, which describes a constellation of observed, subjective, and nonspecific symptoms, has raised significant challenges for clinicians and parents in the evaluation and care of these infants. 3 Although a broad range of disorders can present as an ALTE (eg, child abuse, congenital abnormalities, epilepsy, inborn errors of metabolism, and infections), for a majority of infants who appear well after the event, the risk of a serious underlying disorder or a recurrent event is extremely low. 2 
CHANGE IN TERMINOLOGY AND DIAGNOSIS
The imprecise nature of the original ALTE definition is difficult to apply to clinical care and research. 3 As a result, the clinician is often faced with several dilemmas. First, under the ALTE definition, the infant is often, but not necessarily, asymptomatic on presentation. The evaluation and management of symptomatic infants (eg, those with fever or respiratory distress) need to be distinguished from that of asymptomatic infants. Second, the reported symptoms under the ALTE definition, although often concerning to the caregiver, are not intrinsically life-threatening and frequently are a benign manifestation of normal infant physiology or a self-limited condition. A definition needs enough precision to allow the clinician to base clinical decisions on events that are characterized as abnormal after conducting a thorough history and physical examination. For example, a constellation of symptoms suggesting hemodynamic instability or central apnea needs to be distinguished from more common and less concerning events readily characterized as periodic breathing of the newborn, breath-holding spells, dysphagia, or gastroesophageal reflux (GER). Furthermore, events defined as ALTEs are rarely a manifestation of a more serious illness that, if left undiagnosed, could lead to morbidity or death. Yet, the perceived potential for recurring events or a serious underlying disorder often provokes concern in caregivers and clinicians. 2, 4, 5 This concern can compel testing or admission to the hospital for observation, which can increase parental anxiety and subject the patient to further risk and does not necessarily lead to a treatable diagnosis or prevention of future events. A more precise definition could prevent the overuse of medical interventions by helping clinicians distinguish infants with lower risk. Finally, the use of ALTE as a diagnosis may reinforce the caregivers' perceptions that the event was indeed "life-threatening, " even when it most often was not. For these reasons, a replacement of the term ALTE with a more specific term could improve clinical care and management.
In this clinical practice guideline, a more precise definition is introduced for this group of clinical events: brief resolved unexplained event (BRUE). The term BRUE is intended to better reflect the transient nature and lack of clear cause and removes the "lifethreatening" label. The authors of this guideline recommend that the term ALTE no longer be used by clinicians to describe an event or as a diagnosis. Rather, the term BRUE should be used to describe events occurring in infants younger than 1 year of age that are characterized by the observer as "brief" (lasting <1 minute but typically <20-30 seconds) and "resolved" (meaning the patient returned to baseline state of health after the event) and with a reassuring history, physical examination, and vital signs at the time of clinical evaluation by trained medical providers (Table 1) . For example, the presence of respiratory symptoms or fever would preclude classification of an event as a BRUE. BRUEs are also "unexplained, " meaning that a clinician is unable to explain the cause of the event after an appropriate history and physical examination. Similarly, an event characterized as choking or gagging associated with spitting up is not included in the BRUE definition, because clinicians will want to pursue the cause of vomiting, which may be related to GER, infection, or central nervous system (CNS) disease. However, until BRUE-specific codes are available, for billing and coding purposes, it is reasonable to apply the ALTE International Classification of Diseases, 9th Revision, and International Classification of Diseases, 10th revision, codes to patients determined to have experienced a BRUE (see section entitled "Dissemination and Implementation").
BRUE DEFINITION
Clinicians should use the term BRUE to describe an event occurring in an infant <1 year of age when the observer reports a sudden, brief, and now resolved episode of ≥1 of the following:
• cyanosis or pallor • altered level of responsiveness Moreover, clinicians should diagnose a BRUE only when there is no explanation for a qualifying event after conducting an appropriate history and physical examination (Tables 2 and 3) .
Differences between the terms ALTE and BRUE should be noted. First, the BRUE definition has a strict age limit. Second, an event is only a BRUE if there is no other likely explanation. Clinical symptoms such as fever, nasal congestion, and increased work of breathing may indicate temporary airway obstruction from viral infection. Events characterized as choking after vomiting may indicate a gastrointestinal cause, such as GER. Third, a BRUE diagnosis is based on the clinician's characterization of features of the event and not on a caregiver's perception that the event was life-threatening. Although such perceptions are understandable and important to address, such risk can only be assessed after the event has been objectively characterized by a clinician. Fourth, the clinician should determine whether the infant had episodic cyanosis or pallor, rather than just determining whether "color change" occurred. Episodes of rubor or redness are not consistent with BRUE, because they are common in healthy infants. Fifth, BRUE expands the respiratory criteria beyond "apnea" to include absent breathing, diminished breathing, and other breathing irregularities. Sixth, instead of the less specific criterion of "change in muscle tone, " the clinician should determine whether there was marked change in tone, including e3 The key action statements in this clinical practice guideline do not apply to higher-risk patients but rather apply only to infants who meet the lower-risk criteria by having an otherwise normal history and physical examination.
RISK ASSESSMENT: LOWER-VERSUS HIGHER-RISK BRUE
Patients who have experienced a BRUE may have a recurrent event or an undiagnosed serious condition (eg, child abuse, pertussis, etc) that confers a risk of adverse outcomes. Although this risk has been difficult to quantify historically and no studies have fully evaluated patient-centered outcomes (eg, family experience survey), the systematic review of the ALTE literature identified a subset of BRUE patients who are unlikely to have a recurrent event or undiagnosed serious conditions, are at lower risk of adverse outcomes, and can likely be managed safely without extensive diagnostic evaluation or hospitalization. 3 In the systematic review of ALTE studies in which it was possible to identify BRUE patients, the following characteristics most consistently conferred higher risk: infants <2 months of age, those with a history of prematurity, and those with more than 1 event. There was generally an increased risk from prematurity in infants born at <32 weeks' gestation, and the risk attenuated once infants born at <32 weeks' gestation reached 45 weeks' postconceptional age. Two ALTE studies evaluated the duration of the event. 6, 7 Although duration did not appear to be predictive of hospital admission, it was difficult to discern a BRUE population from the heterogeneous ALTE populations. Nonetheless, most events were less than one minute. By consensus, the subcommittee established <1 minute as the upper limit of a "brief event, " understanding that objective, verifiable measurements were rarely, if ever, available. Cariopulmonary resuscitation (CPR) was identified as a risk factor in the older ALTE studies and confirmed in a recent study, 6 but it was unclear how the need for CPR was determined. Therefore, the committee agreed by consensus that the need for CPR should be determined by trained medical providers.
PATIENT FACTORS THAT DETERMINE A LOWER RISK
To be designated lower risk, the following criteria should be met (see Fig 1) :
• Age >60 days
• Prematurity: gestational age ≥32 weeks and postconceptional age ≥45 weeks
• First BRUE (no previous BRUE ever and not occurring in clusters)
• Duration of event <1 minute
• No CPR required by trained medical provider
• No concerning historical features (see Table 2 )
• No concerning physical examination findings (see Table 3 were searched for studies involving children younger than 24 months by using the stepwise approach specified in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. 8 Search terms included "ALTE(s), " "apparent life threatening event(s), " "life threatening event(s), " "near miss SIDS" or "near miss sudden infant death syndrome, " "aborted crib death" or "aborted sudden infant death syndrome, " and "aborted SIDS" or "aborted cot death" or "infant death, sudden." The Medical Subject Heading "infantile apparent lifethreatening event, " introduced in 2011, was also searched but did not identify additional articles.
In updating the systematic review published in 2012, pairs of 2 subcommittee members used validated methodology to independently score the newly identified abstracts from Englishlanguage articles (n = 120) for relevance to the clinical questions (Supplemental Fig 3) . 9, 10 Two independent reviewers then critically appraised the full text of the identified articles (n = 23) using a structured data collection form based on published guidelines for evaluating medical literature. 11, 12 They recorded each study's relevance to the clinical question, research design, setting, time period covered, sample size, patient eligibility criteria, data source, variables collected, key results, study e6 in the updated (n = 18) and original (n = 37) systematic review (Supplemental Table 7 ). 6, 7, [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] The resulting systematic review was used to develop the guideline recommendations by following the policy statement from the AAP Steering Committee on Quality Improvement and Management, "Classifying Recommendations for Clinical Practice Guidelines." 29 Decisions and the strength of recommendations were based on a systematic grading of the quality of evidence from the updated literature review by 2 independent reviewers and incorporation of the previous systematic review. Expert consensus was used when definitive data were not available. If committee members disagreed with the rest of the consensus, they were encouraged to voice their concern until full agreement was reached. If full agreement could not be reached, each committee member reserved the right to state concern or disagreement in the publication (which did not occur). Because the recommendations of this guideline were based on the ALTE literature, we relied on the studies and outcomes that could be attributable to the new definition of lower-or higher-risk BRUE patients.
Key action statements (summarized in Table 5 ) were generated by using BRIDGE-Wiz (Building Recommendations in a Developers Guideline Editor), an interactive software tool that leads guideline development teams through a series of questions that are intended to create clear, transparent, and actionable key action statements. 30 BRIDGE-Wiz integrates the quality of available evidence and a benefitharm assessment into the final determination of the strength of each recommendation. Evidence-based guideline recommendations from the AAP may be graded as strong,
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FIGURE 2
AAP rating of evidence and recommendations.
TABLE 4 Guideline Defi nitions for Key Action Statements
Statement
Defi nition Implication
Strong recommendation A particular action is favored because anticipated benefi ts clearly exceed harms (or vice versa) and quality of evidence is excellent or unobtainable.
Clinicians should follow a strong recommendation unless a clear and compelling rationale for an alternative approach is present. Moderate recommendation A particular action is favored because anticipated benefi ts clearly exceed harms (or vice versa) and the quality of evidence is good but not excellent (or is unobtainable).
Clinicians would be prudent to follow a moderate recommendation but should remain alert to new information and sensitive to patient preferences. Weak recommendation (based on lowquality evidence)
A particular action is favored because anticipated benefi ts clearly exceed harms (or vice versa), but the quality of evidence is weak.
Clinicians would be prudent follow a weak recommendation but should remain alert to new information and very sensitive to patient preferences. Weak recommendation (based on balance of benefi ts and harms)
Weak recommendation is provided when the aggregate database shows evidence of both benefi t and harm that appear to be similar in magnitude for any available courses of action.
Clinicians should consider the options in their decision-making, but patient preference may have a substantial role.
moderate, weak based on low-quality evidence, or weak based on balance between benefits and harms. Strong and moderate recommendations are associated with "should" and "should not" recommendation statements, whereas weak recommendation may be recognized by use of "may" or "need not" (Fig 2, This guideline is intended for use primarily by clinicians providing care for infants who have experienced a BRUE and their families. This guideline may be of interest to parents and payers, but it is not intended to be used for reimbursement or to determine insurance coverage. This guideline is not intended as the sole source of guidance in the evaluation and management of BRUEs but rather is intended to assist clinicians by providing a framework for clinical decision-making.
KEY ACTION STATEMENTS FOR LOWER-RISK BRUE
Cardiopulmonary
1A. Clinicians Need Not Admit Infants Presenting With a LowerRisk BRUE to the Hospital Solely for Cardiorespiratory Monitoring (Grade B, Weak Recommendation)
Infants presenting with an ALTE often have been admitted for observation and testing. Observational data indicate that 12% to 14% of infants presenting with a diagnosis of ALTE had a subsequent event or condition that required hospitalization. 7, 31 Thus, research has sought to identify risk factors that could be used to identify infants likely to benefit from hospitalization. A long-term follow-up study in infants hospitalized with an ALTE showed that no infants subsequently had SIDS but 11% were victims of child abuse and 4.9% had adverse neurologic outcomes (see 3. Neurology). 32 The ALTE literature supports that infants presenting with a lower-risk BRUE do not have an increased rate of cardiovascular or other events during admission and hospitalization may not be required, but close follow-up is recommended. Careful outpatient follow-up is advised (repeat clinical history and physical examination within 24 hours after the initial evaluation) to identify infants with ongoing medical concerns that would indicate further evaluation and treatment.
Al-Kindy et al 33 of postconceptional age). However, no adverse outcomes were noted for any of their cohort (although whether there is a protective effect of observation alone is not known). Some of the infants with extreme events developed symptoms of upper respiratory infection 1 to 2 days after the ALTE presentation. The risk factors for "extreme" events were prematurity, postconceptional age <43 weeks, and (presence of) upper respiratory infection symptoms. Importantly, infants with a postconceptional age >48 weeks were not documented as having an extreme event in this cohort. A previous longitudinal study also identified "extreme" events that occurred with comparable frequency in otherwise normal term infants and that were not statistically increased in term infants with a history of ALTE. 34 Preterm infants have been shown to have more serious events, although an ALTE does not further increase that risk compared with asymptomatic preterm infants without ALTE. 34 Claudius and Keens 31 performed an observational prospective study in 59 infants presenting with ALTE who had been born at >30 weeks' gestation and had no significant medical illness. They evaluated factors in the clinical history and physical examination that, according to the authors, would warrant hospital admission on the basis of adverse outcomes (including recurrent cardiorespiratory events, infection, child abuse, or any lifethreatening condition). Among these otherwise well infants, those with multiple ALTEs or age <1 month experienced adverse outcomes necessitating hospitalization. Prematurity was also a risk factor predictive of subsequent adverse events after an ALTE. Paroxysmal decreases in oxygen saturation in infants immediately before and during viral illnesses have been well documented. 33, 35 However, the significance of these brief hypoxemic events has not been established.
1B. Clinicians May Briefl y Monitor Infants Presenting With a Lower-Risk BRUE With Continuous Pulse Oximetry and Serial Observations (Grade D, Weak Recommendation)
A normal physical examination, including vital signs and oximetry, is needed for a patient who has experienced a BRUE to be considered lower-risk. An evaluation at a single point in time may not be as accurate as a longer interval of observation. Unfortunately, there are few data to suggest the optimal duration of this period, the value of repeat examinations, and the effect of false-positive evaluations on familycentered care. Several studies have documented intermittent episodes of hypoxemia after admission for ALTE. 7, 31, 33 Pulse oximetry identified more infants with concerning paroxysmal events than cardiorespiratory monitoring alone. 33 However, occasional oxygen desaturations are commonly observed in normal infants, especially during sleep. 36 Furthermore, normative oximetry data are dependent on the specific machine, averaging interval, altitude, behavioral state, and postconceptional age. Similarly, there may be considerable variability in the vital signs and the clinical appearance of an infant. Pending further research into this important issue, clinicians may choose to monitor and provide serial examinations of infants in the lower-risk group for a brief period of time, ranging from 1 to 4 hours, to establish that the vital signs, physical examination, and symptomatology remain stable.
1C. Clinicians Should Not Obtain a Chest Radiograph in Infants Presenting With a Lower-Risk BRUE (Grade B, Moderate Recommendation)
Infectious processes can precipitate apnea. In 1 ALTE study, more than 80% of these infections involved the respiratory tract. 37 Most, but not all, infants with significant lower respiratory tract infections will be symptomatic at the time of ALTE presentation. However, 2 studies have documented pneumonia in infants presenting with ALTE and an otherwise noncontributory history and physical examination. 4, 37 These rare exceptions have generally been in infants younger than 2 months and would have placed them in the higher-risk category for a BRUE in this guideline. Similarly, Davies and Gupta 38 reported that 9 of 65 patients (ages unknown) who had ALTEs had abnormalities on chest radiography (not fully specified) despite no suspected respiratory disorder on clinical history or physical examination. Some of the radiographs were performed up to 24 hours after presentation. Davies and Gupta further reported that 33% of infants with ALTEs that were ultimately associated with a respiratory disease had a normal initial respiratory examination. 38 Kant et al 18 reported that 2 of 176 infants discharged after admission for ALTE died within 2 weeks, both of pneumonia. One infant had a normal chest radiograph initially; the other, with a history of prematurity, had a "possible" infiltrate. Thus, most experience has shown that a chest radiograph in otherwise well-appearing infants rarely alters clinical management. 7 Careful follow-up within 24 hours is important in infants with a nonfocal clinical history and physical examination to identify those who will ultimately have a lower respiratory tract infection diagnosed.
1D. Clinicians Should Not Obtain Measurement of Venous or Arterial Blood Gases in Infants Presenting With a Lower-Risk BRUE (Grade B, Moderate Recommendation)
Blood gas measurements have not been shown to add significant clinical information in otherwise well-appearing infants presenting with an ALTE. 4 Although not part of this guideline, future research may demonstrate that blood gases are helpful in select infants with a higher risk BRUE to support the diagnosis of pulmonary disease, control-ofbreathing disorders, or inborn errors of metabolism (IEMs). 40 However, without a control population, the clinical significance of these events is uncertain, because respiratory pauses are frequently observed in otherwise normal infants. 35 Similarly, Kahn and Blum 41 reported that 10 of 71 infants with a clinical history of "benign" ALTEs had an abnormal polysomnograph, including periodic breathing (7 of 10) or obstructive apnea (4 of 100), but specific data were not presented. These events were not found in a control group of 181 infants. The severity of the periodic breathing (frequency of arousals and extent of oxygen desaturation) could not be evaluated from these data. Daniëls et al 42 performed polysomnography in 422 infants with ALTEs and identified 11 infants with significant bradycardia, OSA, and/or oxygen desaturation. Home monitoring revealed episodes of bradycardia (<50 per minute) in 7 of 11 infants and concluded that polysomnography is a useful modality. However, the clinical history, physical examination, and laboratory findings were not presented. GER has also been associated with specific episodes of severe bradycardia in monitored infants. 43 Overall, most polysomnography studies have shown minimal or nonspecific findings in infants presenting with ALTEs. 44, 45 Polysomnography studies generally have not been predictive of ALTE recurrence and do not identify those infants at risk of SIDS. 46 Thus, the routine use of polysomnography in infants presenting with a lower-risk BRUE is likely to have a low diagnostic yield and is unlikely to lead to changes in therapy.
1E. Clinicians Should Not Obtain an
OSA has been occasionally associated with ALTEs in many series, but not all. 39, [47] [48] [49] comprehensive clinical history and physical examination. 50 Symptoms of OSA, which may be subtle or absent in infants, include snoring, noisy respirations, labored breathing, mouth breathing, and profuse sweating. 51 Occasionally, infants with OSA will present with failure to thrive, witnessed apnea, and/ or developmental delay. 52 Snoring may be absent in younger infants with OSA, including those with micrognathia. In addition, snoring in otherwise normal infants is present at least 2 days per week in 11.8% and at least 3 days per week in 5.3% of infants. 53 Some infants with OSA may be asymptomatic and have a normal physical examination. 54 However, some studies have reported a high incidence of snoring in infants with (26%-44%) and without (22%-26%) OSA, making the distinction difficult. 55 or novel gene findings at the long QT loci. 60 A syncopal episode, which could present as a BRUE, is strongly associated with subsequent sudden cardiac arrest in patients with long QT syndrome. 61 The incidence and risk in those with other channelopathies have not been adequately studied. Child abuse is a common and serious cause of an ALTE. Previous research has suggested that this occurs in up to 10% of ALTE cohorts. 3, 67 Abusive head trauma is the most common form of child maltreatment associated with an ALTE. Other forms of child abuse that can present as an ALTE, but would not be identified by radiologic evaluations, include caregiver-fabricated illness (formally known as Münchausen by proxy), smothering, and poisoning.
Children who have experienced child abuse, most notably abusive head trauma, may present with a BRUE. Four studies reported a low incidence (0.54%-2.5%) of abusive head trauma in infants presenting to the emergency department with an ALTE. 22, 37, 67, 69 If only those patients meeting lower-risk BRUE criteria were included, the incidence of abusive head trauma would have been <0.3%. Although missing abusive head trauma can result in significant morbidity and mortality, the yield of performing neuroimaging to screen for abusive head trauma is extremely low and has associated risks of sedation and radiation exposure. 32, 70 Unfortunately, the subtle presentation of child abuse may lead to a delayed diagnosis of abuse and result in significant morbidity and mortality. 70 In previously described ALTE cohorts, abnormal physical findings were associated with an increased risk of abusive head trauma. These findings include bruising, subconjunctival hemorrhage, bleeding from the nose or mouth, and a history of rapid head enlargement or head circumference >95th percentile. 67, [70] [71] [72] [73] [74] It is important to perform a careful physical examination to identify subtle findings of child abuse, including a large or full/bulging anterior fontanel, scalp bruising or bogginess, oropharynx or frenula damage, or skin findings such as bruising or petechiae, especially on the trunk, face, or ears. A normal physical examination does not rule out the possibility of abusive head trauma. Although beyond the scope of this guideline, it is important for the clinician to note that according to the available evidence, brain neuroimaging is probably indicated in patients who qualify as higher-risk because of concerns about abuse resulting from abnormal history or physical findings. 67 A social and environmental assessment should evaluate the risk of intentional poisoning, unintentional poisoning, and environmental exposure (eg, home environment), because these can be associated with the symptoms of ALTEs in infants. [75] [76] [77] [78] In 1 study, 8.4% of children presenting to the emergency department after an ALTE were found to have a clinically significant, positive comprehensive toxicology screen. 76 Ethanol or other drugs have also been associated with ALTEs. 79 Pulmonary hemorrhage can be caused by environmental exposure to moldy, water-damaged homes; it would usually present with hemoptysis and thus probably would not qualify as a BRUE. 80 
Neurology
3A. Clinicians Should Not Obtain Neuroimaging (Computed Tomography, MRI, or Ultrasonography) To Detect Neurologic Disorders in Infants Presenting With a Lower-Risk BRUE (Grade C, Moderate Recommendation)
Epilepsy or an abnormality of brain structure can present as a lowerrisk BRUE. CNS imaging is 1 method for evaluating whether underlying abnormalities of brain development or structure might have led to the BRUE. The long-term risk of a diagnosis of neurologic disorders ranges from 3% to 11% in historical cohorts of ALTE patients. 2, 32 One retrospective study in 243 ALTE patients reported that CNS imaging contributed to a neurologic diagnosis in 3% to 7% of patients. 4 However, the study population included all ALTEs, including those with a significant past medical history, nonwell-appearing infants, and those with tests ordered as part of the emergency department evaluation.
In a large study of ALTE patients, the utility of CNS imaging studies in potentially classifiable lowerrisk BRUE patients was found to be low. 32 The cohort of 471 patients was followed both acutely and long-term for the development of epilepsy and other neurologic disorders, and the sensitivity and positive-predictive value of abnormal CNS imaging for subsequent development of epilepsy was 6.7% (95% confidence interval [CI]: 0.2%-32%) and 25% (95% CI: 0.6%-81%), respectively.
The available evidence suggests minimal utility of CNS imaging to evaluate for neurologic disorders, including epilepsy, in lower-risk patients. This situation is particularly true for pediatric epilepsy, in which even if a patient is determined ultimately to have seizures/epilepsy, there is no evidence of benefit from starting therapy after the first seizure compared with starting therapy after a second seizure in terms of achieving seizure remission. [81] [82] [83] However, our recommendations for BRUEs are not based on any prospective studies and only on a single retrospective study. Future work should track both short-and long-term neurologic outcomes when considering this issue.
3B. Clinicians Should Not Obtain an EEG To Detect Neurologic Disorders in Infants Presenting With a LowerRisk BRUE (Grade C, Moderate Recommendation)
Epilepsy may first present as a lowerrisk BRUE. The long-term risk of epilepsy ranges from 3% to 11% in historical cohorts of ALTE patients. 2, 32 EEG is part of the typical evaluation for diagnosis of seizure disorders. However, the utility of obtaining an EEG routinely was found to be low in 1 study. 32 In a cohort of 471 ALTE patients followed both acutely and long-term for the development of epilepsy, the sensitivity and positivepredictive value of an abnormal EEG for subsequent development of epilepsy was 15% (95% CI: 2%-45%) and 33% (95% CI: 4.3%-48%), respectively. In contrast, another retrospective study in 243 ALTE patients reported that EEG contributed to a neurologic diagnosis in 6% of patients. 4 This study e16 by guest on March 22, 2018 http://pediatrics.aappublications.org/ Downloaded from population differed significantly from that of Bonkowsky et al 32 in that all ALTE patients with a significant past medical history and non-wellappearing infants were included in the analysis and that tests ordered in the emergency department evaluation were also included in the measure of EEG yield.
A diagnosis of seizure is difficult to make from presenting symptoms of an ALTE. 30 Although EEG is recommended by the American Academy of Neurology after a firsttime nonfebrile seizure, the yield and sensitivity of an EEG after a first-time ALTE in a lower-risk child are low. 86 Thus, the evidence available suggests no utility for routine EEG to evaluate for epilepsy in a lower-risk BRUE. However, our recommendations for BRUEs are based on no prospective studies and on only a single retrospective study. Future work should track both short-and longterm epilepsy when considering this issue.
Finally, even if a patient is determined ultimately to have seizures/epilepsy, the importance of an EEG for a first-time ALTE is low, because there is little evidence that shows a benefit from starting therapy after the first seizure compared with after a second seizure in terms of achieving seizure remission. [81] [82] [83] 85 
3C. Clinicians Should Not Prescribe Antiepileptic Medications for Potential Neurologic Disorders in Infants Presenting With a Lower-Risk BRUE (Grade C, Moderate Recommendation)
Once epilepsy is diagnosed, treatment can consist of therapy with an antiepileptic medication. In a cohort of 471 ALTE patients followed both acutely and longterm for the development of epilepsy, most patients who developed epilepsy had a second event within 1 month of their initial presentation. 32, 87 Even if a patient is determined ultimately to have seizures/epilepsy, there is no evidence of benefit from starting therapy after the first seizure compared with starting therapy after a second seizure in terms of achieving seizure remission. [81] [82] [83] 85 Sudden unexpected death in epilepsy (SUDEP) has a frequency close to 1 in 1000 patient-years, but the risks of SUDEP are distinct from ALTEs/ BRUEs and include adolescent age and presence of epilepsy for more than 5 years. These data do not support prescribing an antiepileptic medicine for a first-time possible seizure because of a concern for SUDEP. Thus, the evidence available for ALTEs suggests lack of benefit for starting an antiepileptic medication for a lower-risk BRUE. However, our recommendations for BRUEs are based on no prospective studies and on only a single retrospective study. Future work should track both short-and long-term epilepsy when considering this issue. detected during the initial workup. However, on further review of such cases with serious bacterial infections, these infants did not qualify as lower-risk BRUEs, because they had risk factors (eg, age <2 months) and/or appeared ill and had abnormal findings on physical examination (eg, meningeal signs, nuchal rigidity, hypothermia, shock, respiratory failure) suggesting a possible severe bacterial infection. After eliminating those cases, it appears extremely unlikely that meningitis or sepsis will be the etiology of a lower-risk BRUE. 2-4, 37, 88, 89 Furthermore, performing these tests for bacterial infection may then lead the clinician to empirically treat with antibiotics with the consequent risks of medication adverse effects, intravenous catheters, and development of resistant organisms. Furthermore, false-positive blood cultures (eg, coagulase negative staphylococci, Bacillus species, Streptococcus viridans) are likely to occur at times, leading to additional testing, longer hospitalization and antibiotic use, and increased parental anxiety until they are confirmed as contaminants.
Infectious Diseases
4A. Clinicians Should Not Obtain a
Thus, the available evidence suggests that a complete blood cell count, blood culture, and lumbar puncture are not of benefit in infants with the absence of risk factors or findings from the patient's history, vital signs, and physical examination (ie, a lower-risk BRUE).
4B. Clinicians Need Not Obtain a Urinalysis (Bag or Catheter) in Infants Presenting With a Lower-Risk BRUE (Grade C, Weak Recommendation)
Case series of infants with ALTEs have suggested that a urinary tract infection (UTI) may be detected at the time of first ALTE presentation in up to 8% of cases. 3, 4, 37, 88 Claudius et al 88 provided insight into 17 cases of certain (n = 13) or possible (n = 4) UTI. However, 14 of these cases would not meet the criteria for a lower-risk BRUE on the basis of age younger than 2 months or being illappearing and/or having fever at presentation.
Furthermore, these studies do not always specify the method of urine collection, urinalysis findings, and/or the specific organisms and colony-forming units per milliliter of the isolates associated with the reported UTIs that would confirm the diagnosis. AAP guidelines for the diagnosis and management of UTIs in children 2 to 24 months of age assert that the diagnosis of UTI requires "both urinalysis results that suggest infection (pyuria and/ or bacteruria) and the presence of at least 50 000 colony-forming units/mL of a uropathogen cultured from a urine specimen obtained through catheterization or suprapubic aspirate." 90 Thus, it seems unlikely for a UTI to present as a lower-risk BRUE.
Pending more detailed studies that apply a rigorous definition of UTI to infants presenting with a lower-risk BRUE, a screening urinalysis need not be obtained routinely. If it is decided to evaluate the infant for a possible UTI, then a urinalysis can be obtained but should only be followed up with a culture if the urinalysis has e18 
3C. Clinicians Should Not Prescribe Antiepileptic Medications for Potential Neurologic Disorders in Infants Presenting
4C. Clinicians Should Not Obtain a Chest Radiograph To Assess for Pulmonary Infection in Infants Presenting With a Lower-Risk BRUE (Grade B, Moderate Recommendation)
Chest radiography is unlikely to yield clinical benefit in a wellappearing infant presenting with a lower-risk BRUE. In the absence of abnormal respiratory findings (eg, cough, tachypnea, decreased oxygen saturation, auscultatory changes), lower respiratory tract infection is unlikely to be present.
Studies in children presenting with an ALTE have described occasional cases with abnormal findings on chest radiography in the absence of respiratory findings on history or physical examination. 4, 37 However, the nature of the abnormalities and their role in the ALTE presentation in the absence of further details about the radiography results make it difficult to interpret the significance of these observations. For instance, descriptions of increased interstitial markings or small areas of atelectasis would not have the same implication as a focal consolidation or pleural effusion.
Kant et al, 18 in a follow-up of 176 children admitted for an ALTE, reported that 2 infants died within 2 weeks of discharge and both were found to have pneumonia 
4D. Clinicians Need Not Obtain Respiratory Viral Testing If Rapid Testing Is Available in Infants Presenting With a Lower-Risk BRUE (Grade C, Weak Recommendation)
Respiratory viral infections (especially with respiratory syncytial virus [RSV]) have been reported as presenting with apnea or an ALTE, with anywhere from 9% to 82% of patients tested being positive for RSV. 2, 4, 37, 88 However, this finding was observed predominantly in children younger than 2 months and/or those who were born prematurely. Recent data suggest that apnea or an ALTE presentation is not unique to RSV and may be seen with a spectrum of respiratory viral infections. 90 The data in ALTE cases do not address the potential role of other respiratory viruses in ALTEs or BRUEs.
In older children, respiratory viral infection would be expected to present with symptoms ranging from upper respiratory to lower respiratory tract infection rather than as an isolated BRUE. In addition, until recently and in reports of ALTE patients to date, RSV testing was performed by using antigen detection tests. More recently, automated nucleic acid amplification-based tests have entered clinical practice. These assays are more sensitive than antigen detection tests and can detect multiple viruses from a single nasopharyngeal swab. The use of these tests in future research may allow better elucidation of the role of respiratory viruses in patients presenting with an ALTE in general and whether they play a role in BRUEs.
As a cautionary note, detection of a virus in a viral multiplex assay may not prove causality, because some agents, such as rhinovirus and adenovirus, may persist for periods beyond the acute infection (up to 30 days) and may or may not be related to the present episode. 92 In a lower-risk BRUE without respiratory symptoms testing for viral infection may not be indicated, but in the presence of congestion and/or cough, or recent exposure to a viral respiratory infection, such testing may provide useful information regarding the cause of the child's symptoms and for infection control management. Anticipatory guidance and arranging close follow-up at the initial presentation could be helpful if patients subsequently develop symptoms of a viral infection.
4E. Clinicians May Obtain Testing for Pertussis in Infants Presenting With a Lower-Risk BRUE (Grade B, Weak Recommendation)
Pertussis infection has been reported to cause ALTEs in infants, because it can cause gagging, gasping, and color change followed by respiratory pause. Such infants can be afebrile and may not develop cough or lower respiratory symptoms for several days afterward.
The decision to test a lower-risk BRUE patient for pertussis should consider potential exposures, vaccine history (including intrapartum immunization of the mother as well as the infant's vaccination history), awareness of pertussis activity in the community, and turnaround time for results. Polymerase chain reaction testing for pertussis on a nasopharyngeal specimen, if available, offers the advantage of rapid turnaround time to results. 94 Culture for the organism requires selective media and will take days to yield results but may still be useful in the face of identified risk of exposure. In patients in whom there is a high index of suspicion on the basis of e20 
4D. Clinicians Need Not Obtain Respiratory Viral Testing If Rapid Testing Is Available in Infants Presenting With a Lower-Risk BRUE (Grade C, Weak Recommendation)
Benefi t-harm assessment
The benefi ts of identifying and treating pertussis and preventing apnea and secondary spread outweigh the cost, discomfort, and consequences of false test results and false reassurance; the benefi ts are greatest in at-risk populations (exposed, underimmunized, endemic, and during outbreaks) GER occurs in more than twothirds of infants and is the topic of discussion with pediatricians at one-quarter of all routine 6-month infant visits. 96 GER can lead to airway obstruction, laryngospasm, or aspiration. Although ALTEs that can be attributed to GER symptoms (eg, choking after spitting up) qualify as an ALTE according to the National Institutes of Health definition, importantly, they do not qualify as a BRUE.
GER may still be a contributing factor to a lower-risk BRUE if the patient's GER symptoms were not witnessed or well described by caregivers. However, the available evidence suggests no utility of routine diagnostic testing to evaluate for GER in these patients. The brief period of observation that occurs during an upper gastrointestinal series is inadequate to rule out the occurrence of pathologic reflux at other times, and the high prevalence of nonpathologic reflux that often occurs during the study can encourage false-positive diagnoses. In addition, the observation of the reflux of a barium column into the esophagus during gastrointestinal contrast studies may not correlate with the severity of GER or the degree of esophageal mucosal inflammation in patients with reflux esophagitis. Routine performance of an upper gastrointestinal series to diagnose GER is not justified and should be reserved to screen for anatomic abnormalities associated with vomiting (which is a symptom that precludes the diagnosis of a lower-risk BRUE). 98 Gastroesophageal scintigraphy scans for reflux of 99m Tc-labeled solids or liquids into the esophagus or lungs after the administration of the test material into the stomach. The lack of standardized techniques and agespecific normal values limits the usefulness of this test. Therefore, gastroesophageal scintigraphy is not recommended in the routine evaluation of pediatric patients with GER symptoms or a lowerrisk BRUE. 97 Multiple intraluminal impedance (MII) is useful for detecting both acidic and nonacidic reflux, thereby providing a more detailed picture of esophageal events than pH monitoring. Combined pH/MII testing is evolving into the test of choice to detect temporal relationships between specific symptoms and the reflux of both acid and nonacid gastric contents. In particular, MII has been used in recent years to investigate how GER correlates with respiratory symptoms, such as apnea or cough. Performing esophageal pH +/-impedance monitoring is not indicated in the routine evaluation of infants presenting with a lower-risk BRUE, although it may be considered in patients with recurrent BRUEs and GER symptoms even if these occur independently.
Problems with the coordination of feedings can lead to ALTEs and BRUEs. In a study in Austrian newborns, infants who experienced an ALTE had a more than twofold increase in feeding difficulties (multivariate relative risk: 2.5; 95% CI: 1.3-4.6). 99 In such patients, it is likely that poor suck-swallowbreathe coordination triggered choking or laryngospasm. A clinical speech therapy evaluation may help to evaluate any concerns for poor coordination swallowing with feeding.
5B. Clinicians Should Not Prescribe Acid Suppression Therapy for Infants Presenting With a Lower-Risk BRUE (Grade C, Moderate Recommendation)
The available evidence suggests no proven efficacy of acid suppression therapy for esophageal reflux in patients presenting with a lower-risk BRUE. Acid suppression therapy with H2-receptor antagonists or proton pump inhibitors may be indicated in selected pediatric patients with GER disease (GERD), which is diagnosed in patients when reflux of gastric contents causes troublesome symptoms or complications. 98 Infants with spitting up or throat-clearing coughs that are not troublesome do not meet diagnostic criteria for GERD. Indeed, the inappropriate administration of acid suppression therapy may have harmful adverse effects because it exposes infants to an increased risk of pneumonia or gastroenteritis. 100 GER leading to apnea is not always clinically apparent and can be the cause of a BRUE. Acid reflux into the esophagus has been shown to be temporally associated with oxygen desaturation and obstructive apnea, suggesting that esophageal reflux may be one of the underlying conditions in selected infants presenting with BRUEs. 101 Respiratory symptoms are more likely to be associated with GER when gross emesis occurs at the time of a BRUE, when episodes occur while the infant is awake and supine (sometimes referred to as "awake apnea"), and when a pattern of obstructive apnea is observed while the infant is making respiratory efforts without effective air movement. 102 Wenzl et al 103 reported a temporal association between 30% of the nonpathologic, short episodes of central apnea and GER by analyzing combined data from simultaneous esophageal and cardiorespiratory monitoring. These findings cannot be extrapolated to pathologic infant apnea and may represent a normal protective cessation of breathing during regurgitation. Similarly, Mousa et al 104 analyzed data from 527 apneic events in 25 infants and observed that only 15.2% were temporally associated with GER. Furthermore, there was no difference in the linkage between apneic events and acid reflux (7.0%) and nonacid reflux (8.2%). They concluded that there is little evidence for an association between acid reflux or nonacid reflux and the frequency of apnea. Regression analysis revealed a significant association between apnea and reflux in 4 of 25 infants. Thus, in selected infants, a clear temporal relationship between apnea and ALTE can be shown. However, larger studies have not proven a causal relationship between pathologic apnea and GER. 105 As outlined in the definition of a BRUE, when an apparent explanation for the event, such as GER, is evident at the time of initial evaluation, the patient should be managed as appropriate for the clinical situation. However, BRUEs can be caused by episodes of reflux-related laryngospasm (sometimes referred to as "silent reflux"), which may not be clinically apparent at the time of initial evaluation. Laryngospasm may also occur during feeding in the absence of GER. Measures that have been shown to be helpful in the nonpharmacologic management of GER in infants include avoiding overfeeding, frequent burping during feeding, upright positioning in the caregiver's arms after feeding, and avoidance of secondhand smoke. 106 Thickening feedings with commercially thickened formula for infants without milkprotein intolerance does not alter esophageal acid exposure detected by esophageal pH study but has been shown to decrease the frequency of regurgitation. Given the temporal association observed between GER and respiratory symptoms in selected infants, approaches that decrease the height of the reflux column, the volume of refluxate, and the frequency of reflux episodes may theoretically be beneficial. 98 Combined pH/MII testing has shown that, although the frequency of reflux events is unchanged with thickened formula, the height of the column of refluxate is decreased. Studies have shown that holding the infant on the caregiver's shoulders for 10 to 20 minutes to allow for adequate burping after a feeding before placing the infant in the "back to sleep position" can decrease the frequency of GER in infants. In contrast, placing an infant in a car seat or in other semisupine positions, such as in an infant carrier, exacerbates esophageal reflux and should be avoided. 98 The frequency of GER has been reported to be decreased in breastfed compared with formulafed infants. Thus, the benefits of breastfeeding are preferred over the theoretical effect of thickened formula feeding, so exclusive breastfeeding should be encouraged whenever possible.
e22 IEMs are reported to cause an ALTE in 0% to 5% of cases. 2, 27, 38, 99, 107, 108 On the basis of the information provided by the authors for these patients, it seems unlikely that events could have been classified as a lower-risk BRUE, either because the patient had a positive history or physical examination or a recurrent event. The most commonly reported disorders include fatty acid oxidation disorders or urea cycle disorders. 107, 109 In cases of vague or resolved symptoms, a careful history can help determine whether the infant had not received previous treatment (eg, feeding after listlessness for suspected hypoglycemia). These rare circumstances could include milder or later-onset presentations of IEMs.
5B. Clinicians Should Not Prescribe Acid Suppression Therapy for Infants Presenting
Infants may be classified as being at a higher risk of BRUE because of a family history of an IEM, developmental disabilities, SIDS, or a medical history of abnormal newborn screening results, unexplained infant death, age younger than 2 months, a prolonged event (>1 minute), or multiple events without an explanation. Confirmation that a newborn screen is complete and is negative is an important aspect of the medical history, but the clinician must consider that not all potential disorders are included in current newborn screening panels in the United States.
Lactic Acid
Measurement of lactic acid can result in high false-positive rates if the sample is not collected properly, making the decision to check a lactic acid problematic. In addition, lactic acid may be elevated because of metabolic abnormalities attributable to other conditions, such as sepsis, and are not specific for IEMs.
Only 2 studies evaluated the specific measurement of lactic acid. 27 confirmed in this study. This study also reported a 20% positive yield of testing for a bicarbonate <20 mmol/L and commented that there was a trend for lower bicarbonate and higher lactic acid levels in those with a recurrent event or a definitive diagnosis. The second publication 27 found no elevations of lactate in 4 of 49 children who had an initial abnormal venous blood gas, of which all repeat blood gas measurements were normal.
Serum Bicarbonate
Abnormal serum bicarbonate levels have been studied in 11 infants, of whom 7 had a diagnosis of sepsis or seizures. 38 Brand et al 4 studied 215 infants who had bicarbonate measured and found only 9 abnormal results, and only 3 of these contributed to the final diagnosis. Although unknown, it is most likely that the event in those infants would not have been classified as a BRUE under the new classification, because those infants were most likely symptomatic on presentation.
Serum Glucose
Abnormal blood glucose levels were evaluated but not reported in 3 studies. 4, 38, 110 Although abnormalities of blood glucose can occur from various IEMs, such as medium-chain acyl-coenzyme A dehydrogenase deficiency or other fatty acid oxidation disorders, their prevalence has not been increased in SIDS and near-miss SIDS but could be considered as a cause of higher-risk BRUEs. 111 It is important to clarify through a careful medical history evaluation that the infant was not potentially hypoglycemic at discovery of the event and improved because of enteral treatment, because these disorders will not typically selfresolve without intervention (ie, feeding).
Serum Electrolytes and Calcium
ALTE studies evaluating the diagnostic value of electrolytes, including sodium, potassium, blood urea nitrogen, and creatinine, reported the rare occurrence of abnormalities, ranging from 0% to 4.3%. 4 lower-risk BRUEs. 109 Elevations of ammonia >100 mmol/L were found in 4% of 65 infants, but this publication did not document a confirmed IEM. 38 Weiss et al 27 reported no abnormal elevations of ammonia in 4 infants with abnormal venous blood gas.
Venous or Arterial Blood Gas
Blood gas abnormalities leading to a diagnosis have not been reported in previous ALTE studies. Brand 116 Bystander CPR results in significant improvement in 1-month survival rates in both cardiac and respiratory arrest. [117] [118] [119] Although lower-risk BRUEs are neither a cardiac nor a respiratory arrest, the AAP policy statement on CPR recommends that pediatricians advocate for life-support training for caregivers and the general public. 115 A technical report that accompanies the AAP policy statement on CPR proposes that this can improve overall community health. 115 CPR training has not been shown to increase caregiver anxiety, and in fact, caregivers have reported a sense of empowerment. [120] [121] [122] There are many accessible and effective methods for CPR training (eg, e-learning).
8B. Clinicians Should Educate Caregivers About BRUEs (Grade C, Moderate Recommendation)
Pediatric providers are an important source of this health information and can help guide important conversations around BRUEs. A study by Feudtner et al 123 identified 4 groups of attributes of a "good parent": (1) making sure the child feels loved, (2) focusing on the child's health, (3) advocating for the child and being informed, and (4) ensuring the child's spiritual well-being. Clinicians should be the source of information for caregivers.
Informed caregivers can advocate for their child in all of the attribute areas/domains, and regardless of health literacy levels, prefer being offered choices and being asked for information. 124 A patient-and familycentered care approach results in better health outcomes. 125, 126 
8C. Clinicians Should Use Shared Decision-Making for Infants Presenting With a Lower-Risk BRUE (Grade C, Moderate Recommendation)
Shared decision-making is a partnership between the clinician and the patient and family. 125, 126 The general principles of shared decision-making are as follows: (1) information sharing, (2) respect and honoring differences, (3) partnership and collaboration, (4) negotiation, and (5) care in the context of family and community. 125 The benefits include improved care and outcomes; improved patient, family, and clinician satisfaction; and better use of health resources. 126 It is advocated for by organizations such as the AAP and the Institute of Medicine. 126, 127 The 5 principles can be applied to all aspects of the infant who has experienced a BRUE, through each step (assessment, stabilization, management, disposition, and follow-up). Shared decision-making will empower families and foster a stronger clinician-patient/family alliance as they make decisions together in the face of a seemingly uncertain situation.
DISSEMINATION AND IMPLEMENTATION
Dissemination and implementation efforts are needed to facilitate guideline use across pediatric medicine, family medicine, emergency medicine, research, and patient/family communities. 128 The following general approaches and a Web-based toolkit are proposed for the dissemination and implementation of this guideline. 
Integration of Clinical Workfl ow
An algorithm is provided (Fig 1) for diagnosis and management. Structured history and physical examination templates also are provided to assist in addressing all of the relevant risk factors for BRUEs (Tables 2 and 3 ). Order sets and modified documents will be hosted on a Web-based learning platform that promotes crowd-sourcing.
Administrative and Research
International Classification of Diseases, 9th Revision, and
International Classification of Diseases, 10th Revision, diagnostic codes are used for billing, quality improvement, and research; and new codes for lower-and higher-risk BRUEs will need to be developed. In the interim, the current code for an ALTE (799.82) will need to be used for billing purposes. Efforts will be made to better reflect present knowledge and to educate clinicians and payers in appropriate use of codes for this condition.
Quality Improvement
Quality improvement initiatives that provide Maintenance of Certification credit, such as the AAP's PREP and EQIPP courses, or collaborative opportunities through the AAP's Quality Improvement Innovation Networks, will engage clinicians in the use and improvement of the guideline. By using proposed quality measures, adherence and outcomes can be assessed and benchmarked with others to inform continual improvement efforts. Proposed measures include process evaluation (use of definition and evaluation), outcome assessment (family experience and diagnostic outcomes), and balancing issues (cost and length of visit). Future research will need to be conducted to validate any measures.
FUTURE RESEARCH
The transition in nomenclature from the term ALTE to BRUE after 30 years reflects the expanded understanding of the etiology and consequences of this entity. Previous research has been largely retrospective or observational in nature, with little long-term follow-up data available.
The more-precise definition, the classification of lower-and higherrisk groups, the recommendations for the lower-risk group, and the implementation toolkit will serve as the basis for future research. Important areas for future prospective research include the following.
Epidemiology
• Incidence of BRUEs in all infants (in addition to those seeking medical evaluation)
• Influence of race, gender, ethnicity, seasonality, environmental exposures, and socioeconomic status on incidence and outcomes
Diagnosis
• 
